Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa: An Open-label Cohort Study in Real Clinical Practice

NCT06926192 is registered in ClinicalTrials.gov with Peking Union Medical College as lead sponsor.

NCT NCT06926192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06926192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa: An Open-label Cohort Study in Real Clinical Practice
Lead sponsor
Peking Union Medical College
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2020
Completion date
June 21, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hidradenitis suppurativa (acne inversa), hidradenitis suppurativa (hs), secukinumab